Glarivibart
Glarivibart is a humanized IgG1κ monoclonal antibody inhibitor targeting Respiratory syncytial virus (RSV) fusion F protein (RSV-F) . Glarivibart has significant antiviral activity. Glarivibart can be used for RSV infections research[1].
Product Specifications
CAS Number
3033697-08-1
UNSPSC
12352100
Target
RSV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog